Reply to Serious Adverse Events With Romosozumab Use in Japanese Patients: Need for Clear Formulation of Contraindications Worldwide
- PMID: 32298496
- DOI: 10.1002/jbmr.4000
Reply to Serious Adverse Events With Romosozumab Use in Japanese Patients: Need for Clear Formulation of Contraindications Worldwide
Comment on
-
Serious Adverse Events With Romosozumab Use in Japanese Patients: Need for Clear Formulation of Contraindications Worldwide.J Bone Miner Res. 2020 May;35(5):994-995. doi: 10.1002/jbmr.4001. Epub 2020 Apr 1. J Bone Miner Res. 2020. PMID: 32237088 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources

